Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States |
| gptkbp:ATCCode |
gptkb:R07AX02
|
| gptkbp:brand |
gptkb:Orkambi
|
| gptkbp:CASNumber |
936727-05-8
|
| gptkbp:combines |
gptkb:ivacaftor
|
| gptkbp:developedBy |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:hasMolecularFormula |
C24H18F2N2O5
|
| gptkbp:hasSMILES |
C1=CC(=CC=C1C2=NC(=C(O2)C3=CC=C(C=C3)F)C(=O)N4CCOCC4)C(=O)N5CCOCC5F
|
| https://www.w3.org/2000/01/rdf-schema#label |
lumacaftor
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
CFTR corrector
|
| gptkbp:molecularWeight |
452.41 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
44462760 DB09280 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea shortness of breath upper respiratory tract infection |
| gptkbp:UNII |
K9MR1Q07EA
|
| gptkbp:usedFor |
cystic fibrosis
|
| gptkbp:bfsParent |
gptkb:CFTR_gene
gptkb:CFTR_modulators gptkb:Orkambi |
| gptkbp:bfsLayer |
6
|